Overview This page contains the latest trade data of Antisera and other blood fractions. In 2023, Antisera and other blood fractions were the world's 72nd most traded product, with a total trade of $42.9B. Between 2022 and 2023 the exports of Antisera and other blood fractions grew by 19.9%, from $35.7B to $42.9B. Trade in Antisera and other blood fractions represent 0.19% of total world trade.
Antisera and other blood fractions are a part of Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other....
Exports In 2023 the top exporters of Antisera and other blood fractions were United States ($11.9B), Germany ($9.36B), Switzerland ($4.25B), Austria ($3.84B), and Ireland ($2.01B).
Imports In 2023 the top importers of Antisera and other blood fractions were Germany ($7.53B), United States ($7.06B), Switzerland ($4.61B), Austria ($4.12B), and China ($2.36B).
Ranking Antisera and other blood fractions ranks 1511th in the Product Complexity Index (PCI).